Resistance to quinolones in mycobacteria.

Ohno, H., Koga, H., Kohno, S.. Higashiyama, Y., Miyazaki, Y., Ogawa, K., Yanagihra, K., Yamamoto, Y., Noda, T. & Miyamoto, J. (1994), Evaluation for rapid detection of rifampiein-rcsistant MycobacteHum tuberculosis by polymerase chain reaction-single strand conformation polymorphism. Kekkaku, 69, 773-778. Predieh, M., Doukhan, L., Nair, G. & Smith, I. (1995), Characterization of RNA polymerase and two sigma factor genes from Mycobacterium smegmatis, Mol. MicrobioL, 15, 355-366. Reichmarm, L.B., McDonald, R.J. & Mangura, B.T. (1994), Rifabutin prophylaxis against Mycobacterium avium complex infection. N. Engl. Z MecL, 330, 437-438. Severinov, K., Kashlev, M., Severinova, E., Bass, I., MeWilliams, K., Kutter, E., Nikiforov, V., Snyder, L. & Goldfaxb, A. (1994a), A non-essential domain of Escherichia coli RNA polymerase required for the action of the termination factor Ale. J. Biol. Chem., 269, 14254-9. Sevednov, K., Soushko, M., Goldfarb, A. & Nikiforov, V. (1993), Rifampicin region revisited. New rifampicinresistant and streptolydigin-resistant mutants in the bt .1 subunit of Escherichia coli RNA polymerase. J. BioL Chem., 268, 14820-5. Sevednov, K., Soushko, M., Goldfarb, A. & Nikiforov, V. (1994b), RilR mutations in the beginning of the Escherichia coli rpoB gene. MoL Gen. Genet., 244, 120-126. Suzuki, Y., Katsukawa, C., Inoue, K., Yion, Y., Tasaka, H., Ueba, N. & Makino, M. (1995), Mutations in rpoB gene of rifampiein resistant clinical isolates of Mycobacterium tuberculosis in Japan. Kaanssenshogaku Zasshi, 69, 413-419. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M.J., Matter, L., Schopfer, K. & Bodmer, T. (1993a), Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet, 341, 647-650. Telenti, A., Imboden, P., Marehesi, F., Schmidheini, T. & Bodmer, T. (1993b), Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis. Antimicrob. Agents Chemother., 37, 2054-2058. Tsukamura, M. (1972), The pattern of resistance development to rifampicin in Mycobacterium tuberculosis. Tubercle, 53, 111-117. Weltman, A.C., Righi, S.P., DiFernando, J., G.T., Jovell, R.J. & Driseoll, J.R. (1995), Rifampiein-resistant Mycobacterium tuberculosis. Lancet, 345, 1513. Williams, D.L., Waguespack, C., Eisenaeh, K., Crawford, J.T., Portaels, F., Salfinger, M., Nolan, C.M., Abe, C., Sficht-Gmh, V. & Gillis, T.P. (1994), Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother., 38, 2380-2386. Winder, F.G. (1982), Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of mycobacteria, in "The biology of the mycobacteria" (C. Ratledge & D. Stanford, Vol. 1) (pp. 353-438). Academic Press, New York. Woodley, C.L. & Kilburn, J.O. (1982), In vitro susceptibility of Mycobacterium avium and Mycobacterium tuberculosis strains to a spiropiperidyl rifamycin. Am. Rev. Respir. Dis., 126, 586-587. Yamori, S. & Tsukamura, M. (1991), Paradoxical effect of Tween 80 between the suscel~ibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-intracellulare complex. Microbiol. lmmunoL, 35, 921-926.